A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
NACompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
HIV InfectionsCytopenias
Interventions
DRUG
Zidovudine
DRUG
Sargramostim
Trial Locations (1)
20892
Natl Cancer Institute / HIV / AIDS Malignancy Branch, Bethesda
NCT00002263 - A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine | Biotech Hunter | Biotech Hunter